Quest PharmaTech Inc.

Creative BiolabsBiotechnology & PharmaceuticalsUnited States

67% match

Creative Biolabs is a biotechnology company that provides custom antibody development, engineering, and manufacturing services for pharmaceutical and research projects.

QureTech BioBiotechnology, Drug DiscoverySweden

67% match

QureTech Bio is a biotechnology company that develops treatments to defeat bacterial virulence and restore antibiotic susceptibility, specifically targeting drug-resistant infections such as Staphylococcus aureus. The company serves the pharmaceutical and healthcare sectors by advancing novel antibacterial portfolios and seeking partnership opportunities.

PharmAbcineBiotech, PharmaceuticalsSouth Korea

66% match

PharmAbcine Inc. is a South Korean public company and a bio venture specializing in the research and development of antibody treatments. It operates in pharmaceutical manufacturing.

Knight Therapeutics Inc.GUD · PharmaceuticalsMontreal, Canada

66% matchPublic

Knight Therapeutics Inc., a specialty pharmaceutical enterprise established in Montreal, Canada in 2013, operates globally, with a strong presence across Canada and Latin America. The company's core business revolves around the development, acquisition, in-licensing, out-licensing, promotion, and distribution of a diverse portfolio encompassing pharmaceutical products, consumer health goods, and medical devices. Its extensive product catalog features treatments such as Nerlynx, prescribed for extended adjuvant and metastatic breast cancer; Tafasitamab, used for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib, targeting metastatic cholangiocarcinoma; Trelstar, addressing advanced prostate cancer and pain associated with endometriosis; Vidaza, indicated for myelodysplastic syndrome; Abraxane, for metastatic pancreatic adenocarcinoma; Halaven, for metastatic breast cancer and soft tissue sarcoma; and Lenvima, useful in differentiated thyroid cancer, advanced renal cell cancer, and unresectable hepatocellular carcinoma. The company's offerings further include Ladevina, for multiple myeloma, myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix, for metastatic prostate cancer; Karfib, for relapsed or refractory multiple myeloma; Leprid, for advanced prostate cancer; and Rembre, for chronic myeloid leukemia. For infectious diseases, it provides Ambisome and Cresemba for fungal infections, along with Impavido for leishmaniasis. Other notable products include Exelon, managing mild to moderately severe dementia; Ibsrela, for irritable bowel syndrome with constipation; Salofalk, for ulcerative colitis; Ursofalk, to treat biliary cirrhosis; Imvexxy, for moderate to severe dyspareunia; Bijuva, for moderate to severe vasomotor symptoms linked to menopause in women with intact uteri; Fibridoner, for idiopathic pulmonary fibrosis; Toliscrin DPI, addressing pseudomonas aeruginosa lung infection in patients with cystic fibrosis; Toliscrin 1-2, for severe acute or resistant chronic infections; and Tobradosa Haler, for chronic lung infections. Beyond its product-focused endeavors, Knight Therapeutics Inc. also provides financing to other life science companies and makes strategic investments in life sciences venture capital funds.

Ottimo Pharma is an innovative, clinical-stage private biotechnology company co-founded in 2020 by Medicxi and Jonny Finlay. The company is focused on developing pioneering bi-functional medicines and one-of-a-kind PD-1/VEGFR2 dual-paratopic antibodies to extend the lives of cancer patients.

Reven Holdings IncPharmaceuticalsUnited States

65% matchPrivate

Reven Holdings Inc. is a pharmaceutical company that develops pharmacological solutions and proprietary drug formulations aimed at targeting the root cause of diseases by restoring immune system homeostasis. The company focuses on addressing inflammation-related conditions ranging from cancer to cardiovascular disease.